• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCOVID-19 vaccines

COVID-19 vaccines

Page 75 of 95
An employee checks bottles of diluent inside the pharmaceutical plant Fareva in Poce-sur-Cisse, Central France, on April 22, 2021. Fareva was chosen as the main supplier of the candidate RNA messenger vaccine from the German company CureVac. The site will therefore produce the diluent used in this vaccine.
Health
These four COVID-19 vaccines could soon join the pandemic fight
By David MeyerMay 8, 2021
Vaccine equity: Africa calls for COVID-19 vaccine plants on its shores
Health
Vaccine equity: Africa calls for COVID-19 vaccine plants on its shores
By Janice Kew, Antony Sguazzin and BloombergMay 8, 2021
China is filling the global COVID vaccine shortage left by the U.S. and India
Health
China is filling the global COVID vaccine shortage left by the U.S. and India
By Iain Marlow, Sudhi Ranjan Sen, James Paton and BloombergMay 7, 2021
To raise COVID vaccination rates, rely on primary care physicians
Commentary
To raise COVID vaccination rates, rely on primary care physicians
By Stanley M. BergmanMay 7, 2021
Shares of Asian vaccine makers rebound from patent waiver shock after Merkel intervenes
Finance
Shares of Asian vaccine makers rebound from patent waiver shock after Merkel intervenes
By Gearoid Reidy, Ishika Mookerjee and BloombergMay 7, 2021
Bar owner charged with selling fake COVID vaccination cards
Health
Bar owner charged with selling fake COVID vaccination cards
By Chris MorrisMay 6, 2021
Biden wants to waive patent protections for COVID-19 vaccines. We asked a patent lawyer what happens next
Health
Biden wants to waive patent protections for COVID-19 vaccines. We asked a patent lawyer what happens next
By Grady McGregorMay 6, 2021
Merck takes huge hit for its abandoned COVID-19 drug efforts
Health
Merck takes huge hit for its abandoned COVID-19 drug efforts
By Riley Griffin and BloombergMay 6, 2021
11 states have vaccinated at least 50% of their population
Health
11 states have vaccinated at least 50% of their population
By Erika Fry and Nicolas RappMay 5, 2021
France’s Valneva to raise funds to bolster its inactivated COVID-19 vaccine
Health
France’s Valneva to raise funds to bolster its inactivated COVID-19 vaccine
By Siva SithraputhranMay 5, 2021
Global stocks rebound—but nothing can beat the surge in Dogecoin
Newsletters
Global stocks rebound—but nothing can beat the surge in Dogecoin
By Bernhard WarnerMay 5, 2021
The COVID vaccine is set to make up more than half of Pfizer’s 2021 revenue
Health
The COVID vaccine is set to make up more than half of Pfizer’s 2021 revenue
By Sy MukherjeeMay 4, 2021
A vial of the Sinovac COVID-19 vaccine is seen at a vaccination site in Manila, the Philippines on May 1, 2021.
Health
Europe starts considering a Chinese COVID-19 vaccine for approval
By David MeyerMay 4, 2021
Forget vaccine jabs—next-generation COVID-19 pills and nasal sprays are on their way
Health
Forget vaccine jabs—next-generation COVID-19 pills and nasal sprays are on their way
By Vivienne WaltMay 4, 2021
FDA expected to approve Pfizer’s Covid-19 vaccine for adolescents next week
Health
FDA expected to approve Pfizer’s Covid-19 vaccine for adolescents next week
By Zeke Miller, Jonathan Lemire and The Associated PressMay 4, 2021
1...
  • 73
  • 74
  • 75
  • 76
  • 77
...95
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.